Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation

Aufranc, V.; Farouil, Geoffroy; Abdel‐Rehim, Mohamed; Smadja, P.; Tardieu, M.; Aptel, S.; Guibal, Aymeric

doi:10.1016/j.diii.2019.07.008

Cited by 37 publications

(21 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the setting of the COVID-19 pandemic, IR procedures can be performed both for complication of the disease and for usual interventions especially for oncologic patients (i. e., tumor ablation, implantable ports, intra-arterial treatment and supportive care) [4][5][6]. A subset of intervention have been defined as high-risk interventions because of close proximity to the patient's face or high-risk of aerosolization [3].…”

Section: Discussionmentioning

confidence: 99%

3D-printed face protective shield in interventional radiology: Evaluation of an immediate solution in the era of COVID-19 pandemic

Sapoval

Gaultier

Giudice

et al. 2020

Diagnostic and Interventional Imaging

View full text Add to dashboard Cite

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

show abstract

Section: Discussionmentioning

confidence: 99%

3D-printed face protective shield in interventional radiology: Evaluation of an immediate solution in the era of COVID-19 pandemic

Sapoval

Gaultier

Giudice

et al. 2020

Diagnostic and Interventional Imaging

View full text Add to dashboard Cite

show abstract

“…This study reported similar efficacy and safety between the two techniques. However, this study fails to specify the recurrence and survival rates segmented by tumor type [25]. No prospective studies comparing both ablative techniques are currently available.…”

Section: Stage I Nsclcmentioning

confidence: 93%

“…However, the theoretical superiority of MWA has not resulted in results significantly different from those already reported for RFA: tumor diameter (> 3 cm) and proximity to a large vessel remain the main factors associated with a higher incidence of incomplete treatment [23]. Nevertheless, MWA may allow the treatment of larger tumors than RFA since tissue impedance does not limit the action of MWA [24,25].…”

Section: Ablative Modalities Available For Lung Ablationmentioning

confidence: 99%

Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art

et al. 2021

View full text Add to dashboard Cite

Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications.

show abstract

“…It has been demonstrated that size and safety margins are prognostic factors of successful lung thermal ablation [39], and that median overall survival after lung ablation is beyond 5 years [40]. Microwave ablation seems to induce less pneumothorax than RFA [41]. Furthermore, the risk of prolonged intensive care is moderated when patient have a lung parenchyma without underlying disease even if the possibility of admission in such unit has to be discussed according the general status of the hospital.…”

Section: Lung Metastases and Primary Lung Tumorsmentioning

confidence: 99%

Interventional oncology at the time of COVID-19 pandemic: Problems and solutions

Denys¹,

Guiu²,

Chevallier³

et al. 2020

Diagnostic and Interventional Imaging

View full text Add to dashboard Cite

The COVID-19 pandemic has deeply impacted the activity of interventional oncology in hospitals and cancer centers. In this review based on official recommendations of different international societies, but also on local solutions found in different expert large-volume centers, we discuss the changes that need to be done for the organization, safety, and patient management in interventional oncology. A literature review of potential solutions in a context of scarce anesthesiologic resources, limited staff and limited access to hospital beds are proposed and discussed based on the literature data.

show abstract

Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation

Cited by 37 publications

References 38 publications

3D-printed face protective shield in interventional radiology: Evaluation of an immediate solution in the era of COVID-19 pandemic

3D-printed face protective shield in interventional radiology: Evaluation of an immediate solution in the era of COVID-19 pandemic

Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art

Interventional oncology at the time of COVID-19 pandemic: Problems and solutions

Contact Info

Product

Resources

About